C-reactive protein and atherosclerosis. Is there a causal link?

Area of Science:

• Biochemistry
• Immunology
• Cardiovascular Medicine

Background:

• C-reactive protein (CRP) is recognized as a significant marker for cardiovascular risk.
• Emerging evidence indicates CRP possesses direct proatherogenic properties, contributing to the development of atherosclerosis.
• Studying CRP's role in atherogenesis is challenging due to species-specific biological functions, complicating the establishment of appropriate animal models.

Purpose of the Study:

• To explore the pathogenic properties of C-reactive protein (CRP) in human atherogenesis.
• To investigate the direct effects of CRP on arterial wall cells, including endothelial cells and smooth muscle cells.
• To clarify the molecular mechanisms underlying CRP's interaction with arterial wall cells.

Main Methods:

• Review of existing evidence on CRP's established pathogenic properties, such as binding to low-density lipoprotein (LDL) and complement system activation.
• Examination of reported direct effects of CRP on endothelial cells and smooth muscle cells.
• Discussion of the challenges in developing animal models for CRP research in atherogenesis.

Main Results:

• CRP's known interactions with LDL and the complement system are implicated in its role in human atherogenesis.
• CRP has demonstrated direct effects on arterial wall cells, though the molecular basis remains unclear.
• The development of CRP inhibitors is being pursued by pharmaceutical companies, suggesting therapeutic potential.

Conclusions:

• CRP's proatherogenic properties suggest an active role in human atherogenesis.
• Further research into the molecular interactions of CRP with arterial cells is necessary.
• CRP may represent a viable therapeutic target for cardiovascular disease.